Israel vs Ukraine: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Israel
0.1%
in 2024
Ukraine
0.1%
in 2024
Israel rank
112th
Ukraine rank
112th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Israel
- Ukraine
How they compare
Israel currently reports 0.1% against 0.1% in Ukraine, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Israel ahead.
Israel ranks 112th and Ukraine ranks 112th of 215 countries.
Across the 2 decades both report, Israel averaged higher in 1 and Ukraine in 1.
Head to head by decade
| Decade | Israel | Ukraine | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.2% | 0.0% | Israel |
| 2020s | 0.1% | 0.1% | 0.0% | Ukraine |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Israel or Ukraine?
- Israel, at 0.1% against 0.1% in Ukraine as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Israel and Ukraine?
- 0.0%, with Israel ahead.
- How many years of comparable data are there for Israel and Ukraine?
- 10 years are reported by both, from 2015 to 2024.
- How do Israel and Ukraine rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Israel ranks 112th and Ukraine ranks 112th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.